Back to Search
Start Over
Leukemia inhibitory factor activates cardiac L-Type Ca2+ channels via phosphorylation of serine 1829 in the rabbit Cav1.2 subunit.
- Source :
-
Circulation research [Circ Res] 2004 May 14; Vol. 94 (9), pp. 1242-8. Date of Electronic Publication: 2004 Mar 25. - Publication Year :
- 2004
-
Abstract
- We have previously reported that leukemia inhibitory factor (LIF) gradually increased cardiac L-type Ca2+ channel current (I(CaL)), which peaked at 15 minutes in both adult and neonatal rat cardiomyocytes, and this increase was blocked by the mitogen-activated protein kinase kinase inhibitor PD98059. This study investigated the molecular basis of LIF-induced augmentation of I(CaL) in rodent cardiomyocytes. LIF induced phosphorylation of a serine residue in the alpha(1c) subunit (Ca(v)1.2) of L-type Ca2+ channels in cultured rat cardiomyocytes, and this phosphorylation was inhibited by PD98059. When constructs encoding either a wild-type or a carboxyl-terminal-truncated rabbit Ca(v)1.2 subunit were transfected into HEK293 cells, LIF induced phosphorylation of the resultant wild-type protein but not the mutant protein. Cotransfection of constitutively active mitogen-activated protein kinase kinase also resulted in phosphorylation of the Ca(v)1.2 subunit in the absence of LIF stimulation. In in-gel kinase assays, extracellular signal-regulated kinase phosphorylated a glutathione S-transferase fusion protein of the carboxyl-terminal region of Ca(v)1.2 (residues 1700 through 1923), which contains the consensus sequence Pro-Leu-Ser-Pro. A point mutation within this consensus sequence, which results in a substitution of alanine for serine at residue 1829 (S1829A), was sufficient to abolish the LIF-induced phosphorylation. LIF increased I(CaL) in HEK cells transfected with wild-type Ca(v)1.2 but not with the mutated version. These results provide direct evidence that LIF phosphorylates the serine residue at position 1829 of the Ca(v)1.2 subunit via the actions of extracellular signal-regulated kinase and that this phosphorylation increases I(CaL) in cardiomyocytes.
- Subjects :
- Amino Acid Substitution
Angiotensin II pharmacology
Animals
Animals, Newborn
Aorta
Calcium metabolism
Calcium Channels, L-Type chemistry
Calcium Channels, L-Type genetics
Calcium Channels, L-Type metabolism
Cell Line
Cells, Cultured drug effects
Cells, Cultured metabolism
Consensus Sequence
Flavonoids pharmacology
Humans
Interleukin-6 pharmacology
Kidney
Leukemia Inhibitory Factor
MAP Kinase Kinase 1
Mitogen-Activated Protein Kinase Kinases physiology
Muscle, Smooth, Vascular cytology
Myocytes, Cardiac metabolism
Myocytes, Smooth Muscle drug effects
Myocytes, Smooth Muscle metabolism
Patch-Clamp Techniques
Phosphorylation drug effects
Phosphoserine analysis
Protein Processing, Post-Translational drug effects
Protein Structure, Tertiary
Rabbits
Rats
Rats, Wistar
Recombinant Proteins pharmacology
Sequence Deletion
Species Specificity
Transfection
Calcium Channels, L-Type drug effects
Interleukin-6 physiology
Myocytes, Cardiac drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4571
- Volume :
- 94
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Circulation research
- Publication Type :
- Academic Journal
- Accession number :
- 15044319
- Full Text :
- https://doi.org/10.1161/01.RES.0000126405.38858.BC